• ABOUT ELITE
    • Overview
    • Our Facility
    • Management & Key Employees
    • Our Board
    • Careers
  • PRODUCTS
  • PIPELINE
    • Generic
    • Branded
  • TECHNOLOGY
    • Technology Overview
    • How It Works
    • One Bead System
    • Two Bead System
  • INVESTOR RELATIONS
    • Press Releases
    • Events & Presentations
    • SEC Filings
    • Shareholder Meeting
    • Governance Documents
    • Investor Contacts
    • Email Alerts
logo image
HOME | CAREERS | CONTACT | NEWS |
Share
Skip to content
  • About Elite
    • Overview
    • Management & Key Employees
    • Our Board
    • Careers
  • Products
  • Pipeline
    • Generic
    • Branded
  • Technology
    • Technology Overview
    • How It Works
    • One Bead System
    • Two Bead System
  • Investor Relations
    • Press Releases
    • Events & Presentations
    • SEC Filings
    • Shareholder Meeting
    • Governance Documents
    • Investor Contacts
    • Email Alerts
    • Investor Relations
    • Press Releases
    • Events &
      Presentations
    • SEC Filings
    • Shareholder
      Meeting
    • Governance
      Documents
    • Investor Contacts
    • Email Alerts

Press Releases
 
Select:
Aug 05, 2013
Elite Pharmaceuticals, Inc. Appoints Nasrat Hakim as President and Chief Executive Officer
Jun 21, 2013
Elite Pharmaceuticals, Inc. Reports Financial Results for the
Jun 19, 2013
Elite Pharmaceuticals, Inc. Announces 2013 Fiscal Year End Conference Call on Monday, June 24, 2013
Jun 10, 2013
Elite Laboratories Files Citizen Petition With The Fda On Brompheniramine Maleate And Pseudoephedrine Hcl Extended Release
May 21, 2013
Elite Pharmaceuticals Announces Change In Executive Leadership
Apr 23, 2013
Elite Pharmaceuticals Awarded Second U.S. Patent For Abuse Resistant Drug Formulation
Apr 22, 2013
Elite Pharmaceuticals, Inc. Secures $10 Million Funding Commitment From Lincoln Park Capital Fund, Llc
Apr 11, 2013
Elite Pharmaceuticals, Inc. Announces First Shipment Of Generic Phentermine Capsules
Feb 13, 2013
Elite Pharmaceuticals, Inc. Announces Fiscal Year 2013 Third Quarter Investor Conference Call on Tuesday, February 19, 2013
Feb 06, 2013
Elite Pharmaceuticals Announces Fda Approval Of Supplemental Application For Naltrexone
 9   10   11   12   13     14    15   16   17   18   19 
 <<   <   >   >> 
  • Site Map   |  Privacy  |  Terms Of Use
Copyright © Elite Pharmaceuticals Inc. | All Rights Reserved.
ART™: Abuse-Resistant Technology for a safer healthier you.
Back to top

Privacy
Resize Viewer - Reduce Resize Viewer - Expand Close window